Welcome to our dedicated page for Clearday news (Ticker: CLRD), a resource for investors and traders seeking the latest updates and insights on Clearday stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clearday's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clearday's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Clearday, Inc. (CLRD), a longevity technology company, has announced a merger with Viveon Health Acquisition Corp. (VHAQ), a special purpose acquisition company. The merger aims to transform Clearday from operating senior-care facilities into a high-growth technology business addressing the longevity care crisis. The pro forma equity valuation of the combined company is expected to be approximately $370 million, with 25 million shares issued to Clearday security holders. Additionally, an earn-out of up to 5 million shares may be provided based on profitability milestones. The merger is anticipated to complete in Q3 2023, pending shareholder approval. This strategic move is designed to enhance patient care and operational efficiency in the aging population sector, which is projected to grow at an 8.5% CAGR by 2026.
Clearday, Inc. (CLRD) and Viveon Health Acquisition Corp. (VHAQ) have announced a merger to address the growing need in the senior adult care sector. The combined company's pro forma equity valuation is expected to be approximately $370 million. Clearday is shifting its focus from operating senior-care facilities to providing advanced technological solutions using AI-driven robotics in a Platform-as-a-Service model. The global adult care market is estimated at $1.75 trillion with an 8.5% CAGR by 2026. Jim Walesa will serve as CEO post-merger, with Jagi Gill joining the Board. The merger is projected to finalize in Q3 2023, pending stockholder approvals and customary closing conditions.
Viveon Health Acquisition Corp. has signed a letter of intent for a business combination with Clearday (OTCQX: CLRD), aiming to enhance longevity-tech services for over 130 million Americans by 2030. Clearday specializes in AI-driven care solutions for the aging population, addressing the $1.4 trillion annual costs linked to aging health care. The proposed transaction values Clearday at $250 million, with existing equity holders converting their stakes into the combined entity. Completion of the deal depends on due diligence, a definitive agreement, and approval from both companies' boards and stockholders.
Clearday, Inc. (OTCQX: CLRD) has secured a new contract with the Veterans Administration (VA) for its Adult Day Care services in San Antonio, Texas. This contract comes after Clearday's acquisition of Primrose Lane Adult Day Care in 2021, during which it enhanced its service offerings, including the introduction of Elder Care AI. The company also reported an increase in the VA contract rate by 101% due to its improved service suite. CEO James Walesa anticipates further service expansions into Central Texas, leveraging proprietary AI applications to enhance care for veterans. Clearday aims to make healthcare more accessible and affordable.
Clearday, Inc. (OTCQX: CLRD) has engaged ClearThink Capital LLC to explore opportunities for unlocking the value of its innovative care businesses through a potential deSPAC transaction. This strategic partnership aims to enhance Clearday's services, including its digital care platform, Clearday at Home, and expand its presence in the senior care market. The collaboration with ClearThink, alongside continued support from DelMorgan & Co., positions the company to capitalize on growth alternatives and financing options as it seeks to uplist. CEO James Walesa emphasized that the current stock price undervalues the company's assets, and the team aims to maximize shareholder value following a challenging economic period.